St. Jude Medical is on track to acquire ventricular assist device-maker Thoratec in the fourth quarter of 2015, now that the "go shop" period specified in the merger agreement has ended.
St Jude agreed on July 22 to buy all of the outstanding shares of Thoratec for about $3.4bn in cash, a premium of 40.1% over Thoratec's volume-weighted average trading...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?